Worth reading
35Immaterial
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Agreements reached under this partnership
Discontinuation206APRISM BioLab Co.,LTD
Alliance partnerBoehringer Ingelheim International GmbH
Details of the alliance
- 1
The company provides its small-molecule library compounds to screen for hit compounds against BI's drug discovery targets and receives consideration from BI for use of the compounds.
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
Impact on Business Performance
This matter will have no impact on the company's results for the current fiscal year.
Contract Date18 May 2020Contract PeriodThe agreement was entered into on 18 May 2020 and will terminate on 16 May 2026, its expiration date. Automatic renewal: Not disclosed
| Item | Details |
|---|---|
| Name of alliance partner | Boehringer Ingelheim International GmbH |
| Type of alliance | Discontinuation |
| Details of the alliance | The company provides its small-molecule library compounds to screen for hit compounds against BI's drug discovery targets and receives consideration from BI for use of the compounds. |
| Contract Period | The agreement was entered into on 18 May 2020 and will terminate on 16 May 2026, its expiration date. Automatic renewal: Not disclosed |
| Contract Date | 18 May 2020 |
| Impact on Business Performance | This matter will have no impact on the company's results for the current fiscal year. |
Items this document does not state (17)
Alliance partner's business activitiesAlliance partner's locationAlliance partner's capitalAlliance partner's net salesAlliance partner's operating incomeNumber of shares acquiredAcquisition priceShareholding ratioOverview of the joint ventureOwnership ratioDispatch of directors and officersNumerical targets under the allianceShareholding PolicyDate of board resolutionAlliance start dateShare Acquisition Date and Payment DateChange in major shareholders
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The agreement will terminate upon expiration of its predetermined term because BI notified the company that it does not intend to renew the agreement.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.